• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Harvard Bioscience Inc

+ Add to Watchlist


4.4300 USD 0.0600 1.34%

As of 20:10:00 ET on 09/19/2014.

Snapshot for Harvard Bioscience Inc (HBIO)

Open: 4.4900 Day's Range: 4.4300 - 4.4900 Volume: 38,472
Previous Close: 4.4900 52wk Range: 3.6800 - 5.1500 1-Yr Rtn: +9.36%

Stock Chart for HBIO

No chart data available.
  • HBIO:US 4.4300
  • 1D
  • 1M
  • 1Y
Interactive HBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HBIO

Current P/E Ratio (ttm) 44.9838
Estimated P/E(12/2014) 29.5333
Relative P/E vs. SPX 2.4745
Earnings Per Share (USD) (ttm) 0.0985
Est. EPS (USD) (12/2014) 0.1500
Est. PEG Ratio 1.4767
Market Cap (M USD) 143.07
Shares Outstanding (M) 32.30
30 Day Average Volume 40,298
Price/Book (mrq) 1.4539
Price/Sale (ttm) 1.3133
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HBIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HBIO

Harvard Bioscience, Inc. develops, manufactures, and markets tools used in drug discovery research and pharmaceutical and biotechnology companies, universities, and government laboratories. The Company's tools include proteomics products that allow researchers to purify and analyze proteins and ADMET screening products that test drug candidates.

Jeffrey A Duchemin "Jeff"President/CEO/SecretaryRobert E Gagnon "Rob"CFO/Treasurer
Yoav SibonyVP:Global SalesYong SunVP:Strategic Marketing
More Company Profile & Key Executives for HBIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil